Study
Virtual Reality with Biofeedback May Ease Hallucinations in Schizophrenia
Adding real-time biofeedback to virtual reality therapy could help manage auditory hallucinations in those with schizophrenia.
Brain HealthMental WellnessHearing Health
Summary
In plain language
Researchers have been exploring new ways to help people with schizophrenia who experience auditory hallucinations, like hearing voices. This study looked at combining virtual reality (VR) therapy with biofeedback—a method that helps people learn to control their body's responses, such as heart rate. The study involved participants using VR to visualize and interact with the voices they hear, aiming to reduce their intensity and distress. The addition of biofeedback may help participants manage anxiety during these sessions. This approach shows promise in making the treatment more effective and could lead to better management of symptoms. Seniors interested in innovative therapies might find this development noteworthy, and it is worth discussing with healthcare providers.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study tried a new way to help people with schizophrenia who hear voices. Researchers used virtual reality to create a digital version of the voice, allowing participants to engage with it safely. They also monitored heart rates to understand stress levels.
Participants received 8 sessions of VR therapy, some with added biofeedback to measure stress.
The study found that combining VR with biofeedback might reduce the severity of hearing voices and improve daily life.
Challenges included ensuring comfort during therapy and balancing exposure to the voices.
Seniors should talk to their healthcare providers to see if such therapies could be beneficial in managing similar symptoms.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Virtual Reality with Biofeedback May Ease Hallucinations in Schizophrenia
Published January 2026 · DOI 10.1371/journal.pone.0333716
Opens at the publisher · external site · may require institutional access
Research Quality Score
Assessment
The study is a randomized clinical trial exploring VR-assisted therapy for auditory verbal hallucinations in schizophrenia. While the design is strong, the lack of detailed methodological transparency and specific relevance to seniors limits its applicability to the senior wellness platform.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 6.7/10 | |
| Bias & Methods | 5.0/10 | |
| Statistical Integrity | 5.0/10 | |
| Transparency | 5.0/10 | |
| Conflict of Interest Disclosure | 5.0/10 | |
| Replication / External Validation | 5.0/10 | |
| Relevance to Seniors | 0.0/10 | |
| Journal Quality | 10.0/10 |
Additional Notes
The study's focus on schizophrenia and auditory hallucinations is not directly relevant to the senior population, which affects its relevance score. Further details on methodology and statistical analysis would improve the assessment.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.